Delivery Order SPE2DB20D3101-SPE2DB24FRAF7

Award Date 1/29/24
Potential Completion Date 1/30/24
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin 150mg pharmaceutical products, with a ceiling value of $6,626.06 and an ultimate completion date of August 7, 2024. The contract is a Delivery Order issued under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA,...
This federal contract award, with a ceiling value of $1,032.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin PH 1% Gel, a pharmaceutical product, with a completion date of December 8, 2022. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and...
This federal contract award, valued at $1,684.59, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565158696 - CLINDAMYCIN 60ML 1S, a pharmaceutical product. The contract has a completion date of July 17, 2024 and is a Firm Fixed Price Delivery Order. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,603.82, is for the delivery of Clindamycin PH 1% Solution 60ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a delivery order valued at $1,337.04 for the supply of the pharmaceutical product Clindamycin 60ML. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of August 14, 2024. The contract is not set aside and is a firm fixed-price agreement. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award has a ceiling value of $1,121.36 and is for the delivery of clindamycin phosphate 1% lotion, a topical antibiotic medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for the delivery of Clindamycin 1% Solution, 60 ml to the Defense Logistics Agency (DLA). The firm-fixed-price, $1,043.86 contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 23, 2024, with a completion date of February 26, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which has a Ceiling Value of $6,050.85, is for the delivery of CLINDAMYCIN 600 MG/50 ML-D5W 50ML pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an Ultimate Completion Date of January 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,634.84, is for the delivery of Clindamycin 900 mg/50 ml-D5W 50 ml, a pharmaceutical product. The contract has a completion date of December 12, 2024 and is a firm fixed-price delivery order. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, valued at $1,141.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Clindamycin PH 1% gel, a pharmaceutical product, with a completion date of February 12, 2024. The contract is a firm-fixed-price type and does not have a set-aside designation, indicating it was awarded through full and open competition....
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRAF7
    Delivery Order

This federal contract award, with a ceiling value of $1,161.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Clindamycin PH 1% Solution, a pharmaceutical product, and has an ultimate completion date of January 30, 2024.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 2/27/25, 1:29 PM